XML 41 R28.htm IDEA: XBRL DOCUMENT v3.24.3
Subsequent Events (Details) - USD ($)
9 Months Ended
Nov. 05, 2024
Oct. 22, 2024
Sep. 30, 2024
Sep. 30, 2023
Oct. 20, 2024
Stockholders' equity [Abstract]          
Gross proceeds received through exercise of warrants     $ 501,000 $ 0  
Subsequent Event [Member]          
Stockholders' equity [Abstract]          
Aggregate purchase of warrants (in shares) 1,832,517        
Warrant exercise price per share (in dollars per share) $ 2.1        
Gross proceeds prior to deducting inducement agent fees and estimated offering expenses $ 3,800,000        
Gross proceeds received through exercise of warrants $ 1,300,000        
Subsequent Event [Member] | Series I Warrants and Series II Warrants [Member]          
Stockholders' equity [Abstract]          
Aggregate purchase of warrants (in shares) 3,665,034        
Subsequent Event [Member] | Series I Warrants [Member]          
Stockholders' equity [Abstract]          
Warrant exercise price per share (in dollars per share) $ 1.94        
Warrant expiry period 5 years        
Warrants exercisable period 6 months        
Subsequent Event [Member] | Series II Warrants [Member]          
Stockholders' equity [Abstract]          
Warrant exercise price per share (in dollars per share) $ 1.94        
Warrant expiry period 2 years        
Warrants exercisable period 6 months        
Subsequent Event [Member] | SeaStar Medical Holding Corporation [Member]          
Subsequent Event [Line Items]          
Agreement settlement amount receivable         $ 900,000
Agreement settlement amount received   $ 500,000